Dedicated Research Sites
Phase I-IV Research Facilities
Our UK Sites
MAC Clinical Research operates a private network of dedicated research sites, geographically located across the UK to serve a broad patient demographic. All MAC sites offer excellent transport links to public motorways, providing ease of access to patients across a wide range of therapy areas. Each modern MAC site hosts a highly experienced, professional workforce, fully committed to conducting high-quality clinical studies. This approach to study conduct offers Sponsors significant efficiencies and cost-savings by reaching more patients, across fewer sites, with expedited study timelines.
MAC owns and operates a growing number of state-of-the-art, dedicated research sites, including an MHRA Accredited Phase 1 Unit located in the heart of Manchester at CityLab’s 1.0 on the Manchester Royal Infirmary Campus. MAC’s network of dedicated late-phase sites span high density conurbations with excellent transport links, offering research opportunities to 30 million people within 30 minutes of our facilities across the UK.
MAC’s dedicated research sites are modern, fully furnished, and well-presented throughout, featuring temperature-regulated rooms, advanced laboratory services, and a full complement of sample storage solutions. MAC’s dedicated research sites host an impressive repository of medical technologies and healthcare equipment, enabling effective execution and seamless delivery of ALL clinical trial activities.
MAC’s dedicated research sites offer exceptional residential and day-case accommodation, where professional, compassionate staff understand patients’ needs and expectations. Our sites provide patients and study monitors with a welcoming, pleasant, and dependable environment in which to participate in research activities. MAC’s research sites offer ample free parking, access to local amenities, and free guest Wi-Fi throughout the premises, providing patients with a relaxed and comforting atmosphere for their research experience. By actively engaging directly with patients, our site staff retains more motivated, enthusiastic, and happy participants. MAC values patient needs: we put patient engagement at the centre of our services this level of attention has resulted in a patient retention rate of 86% on long-term studies, and a 94% retention rate on studies active less than 1 year.
MAC employees follow a proven and successful business management model, guided by an extensive library of company policies, standard operating procedures (SOPs), and a comprehensive training framework encompassing ICH GCP guidance. Our sites are clinically governed and follow a centralised management structure. Highly experienced professionals lead, conduct, and direct studies to ensure the highest quality standards and achieve successful study outcomes. MAC employees operate our bespoke Patient Pathway Management System (PPMS), offering integrated Care and Data Management Services between multiple sites and business functions within the organisation. Our PPMS ensures that our clients and patients achieve study milestones both on-budget and on-time, whilst providing sponsors with prompt, high-quality, multi-site study data.